Evidence map›Paper›PMID 37521200›Full record

ArticleTetrahedron letters2022

Conjugate reduction of vinyl bisphosphonates.

Nyema M Harmon, Nathaniel R Gehrke, David F Wiemer

Abstract read
In one paragraph

Article in Tetrahedron letters, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nyema M HarmonDepartment of Chemistry, The University of Iowa, Iowa City, IA 52242-1294, USA.
Nathaniel R GehrkeDepartment of Chemistry, The University of Iowa, Iowa City, IA 52242-1294, USA.
David F WiemerDepartment of Chemistry, The University of Iowa, Iowa City, IA 52242-1294, USA.

Funding

Geranylgeranyl diphosphate synthase inhibitor therapy for multiple myelomaR01CA258621 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI HOLSTEIN, SARAH A, MOHS, AARON M. · 2021 to 2025
$2.5M
NCI NIH HHS R01 CA258621
6 · The paper itself

Abstract

Vinyl bisphosphonates can be readily prepared by condensation of an aromatic aldehyde with the tetraester of a methylenebisphosphonate, and reduction of the resulting olefin is an attractive strategy for the preparation of monoalkyl geminal bisphosphonates. Conjugate reduction through use of variations on the Stryker approach has proven to be an efficient method for that reduction, even in the presence of aromatic substituents that also could be reduced. Furthermore, remote olefins in an isoprenoid chain survive this conjugate reduction unaffected, allowing access to isoprenoid-substituted triazole bisphosphonates of interest as potential inhibitors of terpenoid biosynthesis.

Indexed as

BisphosphonateConjugate reductionIsoprenoid biosynthesisSynthesisTriazole

Identifiers

PMID37521200
PMCPMC10373991

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.